Trial intelligence / Profile preview

Intravenous lidocaine for postoperative pain management in robot-assisted laparoscopic colorectal cancer surgery

2014-003466-25Phase 3Completed

Sponsor
Anders Gadegaard Jensen,Anesthesia and Intensive Care Unit, Odense University Hospital
Start
Oct 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in postoperative pain, Postoperative gastrointestinal dysfunction (POGD) and postoperative nausea and vomiting (PONV) comparing Intravenous lidocaine with Placebo (2 arms). Primary endpoint: Morphine consumption during the first 24 hours postoperatively. Started Oct 2014; status: completed.

02

Drugs

lidocaine
03

Conditions

postoperative painPostoperative gastrointestinal dysfunction (POGD)postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on 2014-003466-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-003466-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call